HYPD.US Hyperion DeFi, Inc.
- Market cap
- USD 39.8M
- P/E
- -
- P/B
- 0.39x
- ROE
- 37.2%
- Dividend yield
- 2.24%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is HYPD.US undervalued?
Graham numberThe Graham number of Hyperion DeFi, Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Hyperion DeFi, Inc. fundamental analysis
No fundamental analysis for Hyperion DeFi, Inc. yet.
Hyperion DeFi, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Hyperion DeFi, Inc.
Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products. The company was formerly know…
Full company profileHyperion DeFi, Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Hyperion DeFi, Inc. annual financial statements
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 2.00M | 14.0M | 0.00 | 3.79K | 57.3K | 813K | 1.88M |
| Gross Profit | 1.20M | 12.4M | 0.00 | -12.2K | -3.87M | 510K | 1.88M |
| Operating Income | -19.8M | -13.0M | -26.9M | -25.4M | -48.7M | -19.0M | -14.3M |
| EBITDA | -19.7M | -12.2M | -26.3M | -24.1M | -46.2M | -43.8M | 4.50M |
| Net Income | -19.8M | -12.8M | -28.0M | -27.3M | -49.8M | -45.3M | 52.8B |
| EPS | -75 | -39 | -67 | -53 | -60 | -9.06 | 3,355 |
| Balance Sheet | |||||||
| Total Assets | 33.9M | 31.7M | 31.0M | 28.8M | 3.67M | 51.8M | 146B |
| Total Liabilities | 18.6M | 11.2M | 13.8M | 19.8M | 16.8M | 10.7M | 4.20B |
| Shareholders' Equity | 15.3M | 20.5M | 17.2M | 9.00M | -13.1M | 41.1M | 142B |
| Cash & Short-term Investments | 28.4M | 19.5M | 22.9M | 14.8M | 2.12M | 6.44M | 6.62B |
| Total Debt | 463K | 7.15M | 10.1M | 16.1M | 11.2M | 8.51M | 529M |
| Cash Flow | |||||||
| Operating Cash Flow | -6.38M | -20.9M | -25.1M | -23.8M | -30.1M | -14.8M | -11.8M |
| Capital Expenditure | 261K | 1.62M | 875K | 3.97M | 161K | 4.00 | 34.7M |
| Free Cash Flow | -6.65M | -22.5M | -26.0M | -27.8M | -30.3M | -14.8M | -11.7B |
| Ratios | |||||||
| ROE | -129.2% | -62.4% | -162.5% | -302.9% | - | -110.4% | 37.2% |
| ROA | -58.3% | -40.4% | -90.3% | -94.7% | -1,358.3% | -87.5% | 36.1% |
| Net Profit Margin | -988.5% | -91.3% | - | -719,859.9% | -86,888.6% | -5,570.6% | 2,805,562.7% |
| Debt to Equity | 0.03x | 0.35x | 0.59x | 1.79x | - | 0.21x | 0.00x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Hyperion DeFi, Inc. dividends
- Dividend yield
- 2.24%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 892K | 0.18 | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:80 on Feb 3, 2025.
Who owns Hyperion DeFi, Inc.
- Insiders 5.33%
- Institutions 19.76%
- Public & others 74.91%
- Shares outstanding 15.4M
- Free float 13.8M
Top funds holding HYPD.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 410K | 2.65% | +40.85% | Sep 2026 |
| Putnam Small Cap Value A | 287K | 1.86% | 0.00% | Sep 2026 |
| Putnam VT Small Cap Value IA | 111K | 0.72% | +97.82% | May 2026 |
| Fidelity Extended Market Index | 82.0K | 0.53% | -0.38% | Sep 2026 |
| Invesco Alerian Galaxy Crypto Eco ETF | 42.9K | 0.28% | 0.00% | Oct 2026 |
| iShares Micro-Cap ETF | 40.4K | 0.26% | 0.00% | Oct 2026 |
| Abante Quant Value FI | 36.0K | 0.23% | 0.00% | Aug 2026 |
| Fidelity Total Market Index | 21.8K | 0.14% | 0.00% | Sep 2026 |
| T. Rowe Price Extended Equity Market Idx | 20.5K | 0.13% | 0.00% | Sep 2026 |
| Fidelity Series Total Market Index | 19.6K | 0.13% | 0.00% | Sep 2026 |
| Fidelity Nasdaq Composite Index | 9.87K | 0.06% | 0.00% | Aug 2026 |
| Vanguard U.S. Eq Idx £ Acc | 8.70K | 0.06% | +8,682.83% | Sep 2026 |
| 1290 VT Micro Cap K | 2.29K | 0.01% | 0.00% | Sep 2026 |
Top institutions holding HYPD.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard Capital Management, LLC | 467K | 3.07% | +453.02% | Jun 2026 |
| Franklin Templeton Inc | 396K | 2.60% | 0.00% | Jun 2026 |
| Arrington Capital Management, LLC | 298K | 1.96% | 0.00% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 238K | 1.57% | 0.00% | Jun 2026 |
| Almanack Investment Partners, LLC. | 169K | 1.11% | 0.00% | Jun 2026 |
| Geode Capital Management, LLC | 131K | 0.86% | +69.57% | Jun 2026 |
| Jane Street Group LLC | 127K | 0.84% | -0.62% | Jun 2026 |
| Oppenheimer & Co Inc | 126K | 0.83% | +96.62% | Jun 2026 |
| BlackRock Inc | 114K | 0.75% | +41.05% | Jun 2026 |
| The Goldman Sachs Group Inc | 91.4K | 0.60% | 0.00% | Jun 2026 |
| Vanguard Fiduciary Trust Co | 74.5K | 0.49% | +164.51% | Jun 2026 |
| Citadel Advisors Llc | 56.3K | 0.37% | -50.14% | Jun 2026 |
| State Street Corp | 54.4K | 0.36% | +110.22% | Jun 2026 |
| UBS Group AG | 33.2K | 0.22% | -32.00% | Jun 2026 |
| Northern Trust Corp | 30.9K | 0.20% | +64.95% | Jun 2026 |
| T. Rowe Price Associates, Inc. | 20.5K | 0.13% | 0.00% | Jun 2026 |
| JPMorgan Chase & Co | 16.1K | 0.11% | +201,237.50% | Jun 2026 |
| XTX Topco Ltd | 12.3K | 0.08% | -51.95% | Jun 2026 |
| Nations Financial Group Inc | 11.1K | 0.07% | 0.00% | Jun 2026 |
| Sanctuary Advisors, LLC | 10.8K | 0.07% | 0.00% | Jun 2026 |
Hyperion DeFi, Inc. company profile
- Company name
- Hyperion DeFi, Inc.
- Ticker
- HYPD.US
- Exchange
- USA Stocks
- Listed since
- Jan 25, 2018
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 9
- Fiscal year end
- December
- Address
- 3090 Nowitzki Way, Dallas, TX, United States, 75219
- Phone
- 833 393 6684
- Website
- hyperiondefi.com
About Hyperion DeFi, Inc.
Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in Dallas, Texas.
Hyperion DeFi, Inc. management
5- Mr. Hyunsu JungCEO, Chief Investment Officer & Director · born 1996
- Mr. David Knox C.F.A.Chief Financial Officer and Treasurer · born 1990
- Mr. Robert RubensteinGeneral Counsel & Secretary · born 1967
- Jason AssadInvestor Contact
- Alexander LoboInvestor Contact